Both ribofuranoside (3) and ribopyranoside (5) of 4-amino-5-cyano-6-methylmercaptopyr-rolo[2, 3-d]pyrimidine (analogs of toyocamycin) have been synthesized for the first time by the fusion procedure using bis-(p-nitrophenyl) hydrogen phosphate as catalyst. Evidence for the β-configuration has been provided by analyzing the NMR spectra and ORD curves. The tumor-inhibitory activity of 3 against Ehrlich ascites carcinoma in mice has also been examined.
References (25)
Related articles (0)
Figures (0)
Content from these authors
Supplementary material (0)
Result List ()
Cited by
This article cannot obtain the latest cited-by information.